Julie A. Mocko
Boston Children's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Julie A. Mocko.
Documenta Ophthalmologica | 2009
Anne B. Fulton; James D. Akula; Julie A. Mocko; Ronald M. Hansen; Ilan Y. Benador; Susanne C. Beck; Edda Fahl; Mathias W. Seeliger; Anne Moskowitz; Maureen E. Harris
A broad spectrum of retinal diseases affects both the retinal vasculature and the neural retina, including photoreceptor and postreceptor layers. The accepted clinical hallmarks of acute retinopathy of prematurity (ROP) are dilation and tortuosity of the retinal vasculature. Additionally, significant early and persistent effects on photoreceptor and postreceptor neural structures and function are demonstrated in ROP. In this paper, we focus on the results of longitudinal studies of electroretinographic (ERG) and vascular features in rats with induced retinopathies that model the gamut of human ROP, mild to severe. Two potential targets for pharmaceutical interventions emerge from the observations. The first target is immature photoreceptors because the status of the photoreceptors at an early age predicts later vascular outcome; this approach is appealing as it holds promise to prevent ROP. The second target is the interplay of the neural and vascular retinal networks, which develop cooperatively. Beneficial pharmaceutical interventions may be measured in improved visual outcome as well as lessening of the vascular abnormalities.
Documenta Ophthalmologica | 2010
James D. Akula; Tara L. Favazza; Julie A. Mocko; Ilan Y. Benador; Ana L. Asturias; Michael S. Kleinman; Ronald M. Hansen; Anne B. Fulton
Prior studies have documented the intertwined developmental courses of retinal blood vessel tortuosity (in fundus photographs) and retinal dysfunction (in electroretinographs) in Sprague–Dawley rat models of retinopathy of prematurity (ROP). Two such models, the “50/10 model” and the “75 model,” are named after the oxygen regimens used to induce retinopathy and are characterized by distinct neurovascular courses that span a range of disease severity. In this study of 50/10 and 75 model rats, retinal flatmounts were used to study the full vasculature at postnatal day (P) 15, P19 and P30. In addition, the layers of the neural retina were measured in toluidine blue-stained cross sections. Finally, gross anatomic features of the eye, including axial length, retinal surface area, and the ratio of anterior to posterior axial-lengths were evaluated. Both clock hours of neovascularization (NV) and percent avascular retina (AR) peaked at P19 and resolved by P30. Through P19, NV was found in every 50/10 model rat, but in only 60% of 75 model rats. AR was positively related to NV. All inner layers of the retina (outer plexiform layer through ganglion cell layer) were attenuated in 50/10 model rats but, in the 75 model, no layer differed significantly from that in controls. The eyes in both ROP models were smaller than those of age-matched controls. The ratio of anterior to posterior axial-lengths ranged from 0.45 in controls through 0.37 in the 75 model to 0.32 in the 50/10 model. Thus, eye growth is altered in these rat models of ROP.
Vision Research | 2008
Ronald M. Hansen; Susan E. Eklund; Ilan Y. Benador; Julie A. Mocko; James D. Akula; Yao Liu; M. Elena Martinez-Perez; Anne B. Fulton
To assess the condition of the retina in children with retinal degeneration due to Bardet-Biedl syndrome (BBS, n=41), Leber congenital amaurosis (LCA, n=31), or Usher syndrome (USH, n=13), the dark adapted visual threshold (DAT) and arteriolar diameters were measured. Compared to controls, the initial DATs of nearly all (83/85) were significantly elevated, and in 26/62 with serial DATs, significant progressive elevation occurred. Arteriolar diameters were significantly attenuated and narrowed with age in BBS and USH, but not LCA. Higher DATs were associated with narrower arterioles. Such non-invasive procedures can document the natural history of these retinal diseases and have the potential to assess response to future treatment.
Investigative Ophthalmology & Visual Science | 2011
Julie A. Mocko; Moon K. Kim; Amanda E. Faulkner; Yang Cao; Vincent T. Ciavatta; Machelle T. Pardue
PURPOSE Subretinal electrical stimulation (SES) from microphotodiode arrays protects photoreceptors in the RCS rat model of retinitis pigmentosa. The authors examined whether mer(kd) mice, which share a Mertk mutation with RCS rats, showed similar neuroprotective effects from SES. METHODS Mer(kd) mice were implanted with a microphotodiode array at postnatal day (P) 14. Weekly electroretinograms (ERGs) followed by retinal histology at week 4 were compared with those of age-matched controls. RT-PCR for fibroblast growth factor beta (Fgf2), ciliary nerve trophic factor (Cntf), glial-derived neurotrophic factor (Gdnf), insulin growth factor 1 (Igf1), and glial fibrillary acidic protein (Gfap) was performed on retinas at 1 week after surgery. Rates of degeneration using ERG parameters were compared between mer(kd) mice and RCS rats from P28 to P42. RESULTS SES-treated mer(kd) mice showed no differences in ERG a- and b-wave amplitudes or photoreceptor numbers compared with controls. However, the expression of Fgf2 and Cntf was greater (6.5 ± 1.9- and 2.5 ± 0.5-fold, respectively; P < 0.02) in SES-treated mer(kd) retinas. Rates of degeneration were faster for dark-adapted maximal b-wave, log σ, and oscillatory potentials in mer(kd) mice than in RCS rats. CONCLUSIONS Although SES upregulated Fgf2 in mer(kd) retinas, as reported previously for RCS retinas, this was not accompanied by neuroprotection of photoreceptors. Comparisons of ERG responses from mer(kd) mice and RCS rats across different ages showed inner retinal dysfunction in mer(kd) mice but not in RCS rats. This inner retinal dysfunction and the faster rate of degeneration in mer(kd) mice may produce a retinal environment that is not responsive to neuroprotection from SES.
Investigative Ophthalmology & Visual Science | 2007
James D. Akula; Julie A. Mocko; Anne Moskowitz; Ronald M. Hansen; Anne B. Fulton
Molecular Vision | 2008
James D. Akula; Julie A. Mocko; Ilan Y. Benador; Ronald M. Hansen; Tara L. Favazza; Tanya C. Vyhovsky; Anne B. Fulton
Experimental Eye Research | 2010
James D. Akula; Ronald M. Hansen; Radouil Tzekov; Tara L. Favazza; Tanya C. Vyhovsky; Ilan Y. Benador; Julie A. Mocko; David McGee; Ryo Kubota; Anne B. Fulton
Molecular Vision | 2013
Vincent T. Ciavatta; Julie A. Mocko; Moon K. Kim; Machelle T. Pardue
Investigative Ophthalmology & Visual Science | 2009
Tara L. Favazza; Ilan Y. Benador; Julie A. Mocko; Tanya C. Vyhovsky; Ronald M. Hansen; Anne B. Fulton; James D. Akula
Investigative Ophthalmology & Visual Science | 2008
Julie A. Mocko; James D. Akula; Ilan Y. Benador; A. Di Nardo; Ronald M. Hansen; Anne B. Fulton